Rapid Response 2017 program

Rapid Response 2017 program

Geplaatst op 7 oktober 2016

The prevalence of neurodegenerative diseases of aging is high and growing rapidly. The Netherlands: Rapid Response 2017 program was created to jumpstart the development of safe and effective treatments for these diseases. The program provides seed funding for novel, high-risk, high-reward translational research projects in the Netherlands. Proposed projects may relate to any disease; however, the basis for selection will be on the potential impact of the project on neurodegenerative diseases of aging.


Projects can request up to €200,000 over up to 2 years for novel, high-risk, high-reward translational research that accelerates the development of therapeutics for neurodegenerative diseases of aging.


The Principal Applicant must be either a researcher at or above the level of Universitair Docent (or equivalent) or a researcher at or above the level of Post-doctoral Fellow with an Administrative Supervisor at a Public Benefit Organisation in the Netherlands.

Application Process

There are two stages to the application process: Letter of Intent (LOI) and Proposal stages. An application requires the submission of a Letter of Intent which will be reviewed by our Scientific Review Committee. Applicants with high potential projects will be invited to submit a Proposal; instructions will be forwarded along with the invitation in December, 2016.

More information

The Institute welcomes inquiries about this request for applications or any of our other funding opportunities. More information about this call can be found on the website of the Weston Brain Institute.


We would be pleased to hear from you at either neuro@weston.ca or +1 416-935-4056.